Cytogenetic analysis of 52 Indian patients with de novo myelodysplastic syndromes-a comparative analysis of results with reports from Asia

Dakshinamurthy, Amirtha Ganesh; Novitzky, Nicolas; Bharadwaj, Raghva; Prakhya, Balakrishna Murthy
May 2005
Annals of Hematology;May2005, Vol. 84 Issue 5, p298
Academic Journal
Most published data on myelodysplastic syndromes (MDS) are derived from Western countries, which report MDS as a disease of the elderly. However, it was observed that Asian MDS patients were younger than subjects in Western reports. With this in mind, the study was conducted prospectively on 52 Indian patients to define chromosomal abnormalities and to understand ethno-geographical differences, if any, underlying the pathogenesis of MDS among this Asian population. Cytogenetic analysis was performed using GTG banding and karyotyped according to the International System for Human Cytogenetic Nomenclature (ISCN). The incidence of MDS was predominant in the age group of 41-60 years (44.23%), with a median age at diagnosis of 55 years. The disease was more frequent in males (33 patients, 63.46%) than females (19 patients, 36.53%). Of 48 patients successfully karyotyped, 17 had normal karyotype (35.4%) and 31 patients (64.5%) had a chromosomal abnormality. The most frequent chromosome abnormalities were del 5q/-5 in 13 patients (42%), -7/7q- in 10 patients (32.2%), +8 and del 20q- in 6 cases each (19.3%) and i(17)(q10) in 1 patient (3.2%). In addition to these non-random chromosomal abnormalities, some rare abnormalities were also encountered. A higher rate of transformation to acute myeloid leukaemia (AML) was observed in the Chinese population compared to other Asian countries. The incidence of chromosomal abnormalities varied considerably across the different Asian populations. The overall frequency of chromosomal abnormalities in our study was comparable to most Western reports. Further prospective studies are warranted to elucidate precisely the ethnic differences in the pathogenesis of MDS in the Indian population.


Related Articles

  • Audit Of Myelodysplastic Syndrome Cases Submitted For Cytogenetic Analysis Over A Two Year Period. Kelly, Johanna; Conneally, Eibhlin; Vandenburgh, Elizabeth; Lynch, Sally Ann // Ulster Medical Journal;2008, Vol. 77 Issue 1, p72 

    Background: Myelodysplastic Syndromes (MDS) are a group of conditions of progressive bone marrow failure of normal maturation leading to peripheral cytopenias. More than one cell lineage is involved, with often up to three. It is typically a disease of the elderly. There is a 20-40% risk of...

  • Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera. Swolin, Birgitta; Rödjer, Stig; Westin, Jan // Annals of Hematology;Jun2008, Vol. 87 Issue 6, p467 

    A minor fraction of patients with polycythemia vera (PV) develop a terminal acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Analysis of the cytogenetic abnormalities during AML or MDS may help in understanding if this development is part of the natural course of the disease or...

  • Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Mallo, M.; Cervera, J.; Schanz, J.; Such, E.; García-Manero, G.; Luño, E.; Steidl, C.; Espinet, B.; Vallespí, T.; Germing, U.; Blum, S.; Ohyashiki, K.; Grau, J.; Pfeilstöcker, M.; Hernández, J. M.; Noesslinger, T.; Giagounidis, A.; Aul, C.; Calasanz, M. J.; Martín, M. L. // Leukemia (08876924);Jan2011, Vol. 25 Issue 1, p110 

    This cooperative study assessed prognostic factors for overall survival (OS) and risk of transformation to acute myeloid leukemia (AML) in 541 patients with de novo myelodysplastic syndrome (MDS) and deletion 5q. Additional chromosomal abnormalities were strongly related to different patients'...

  • 5q— myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. Eisenmann, K. M.; Dykema, K. J.; Matheson, S. F.; Kent, N. F.; DeWard, A. D.; West, R. A.; Tibes, R.; Furge, K. A.; Alberts, A. S. // Oncogene;10/1/2009, Vol. 28 Issue 39, p3429 

    Complete loss or interstitial deletions of chromosome 5 are the most common karyotypic abnormality in myelodysplastic syndromes (MDSs). Isolated del(5q)/5q– MDS patients have a more favorable prognosis than those with additional karyotypic defects, who tend to develop myeloproliferative...

  • Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. He Qi; Li Xiao; Wu Lingyun; Tao Ying; Liu Yi-Zhi; Ying Shao-Xu; Pu Quan // Annals of Hematology;Feb2006, Vol. 85 Issue 2, p95 

    To verify the expression of type 1 insulin-like growth factor receptor (IGF-IR) and its impact on hematopoietic cells apoptosis in myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML), marrow samples from 16 patients with MDS and 16 patients with AML were examined along with 16...

  • Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Lezon-Geyda, K; Najfeld, V; Johnson, E M // Leukemia (08876924);Jun2001, Vol. 15 Issue 6, p954 

    Deletions or monosomy of chromosomes 5 and 7 are frequently observed in myelodysplastic syndromes (MDS) and acute myel-ogenous leukemia (AML). In this study two genes, PURA and PURB, encoding functionally cooperative proteins in the Pur family, are localized to chromosome bands 5q31.1 and 7p13,...

  • Miyelodisplastik sendrom olgularında sitogenetik analiz sonuçlarının hasta prognozuna etkisi. Güran, Şefik; Beyan, Cengiz; Tunca, Yusuf; Kozan, Salih; Torun, Deniz; Ifran, Ahmet; Kaptan, Kürşat; Ural, Ali Uğur; Nevruz, Oral; Avcu, Ferit; Çetin, Türker; Gü, Davut; Bahçe, Muhterem // Gulhane Medical Journal;Jun2011, Vol. 53 Issue 2, p104 

    Cytogenetic analysis has a significant role in establishing diagnosis and prognostic evaluation of patients with myelodysplastic syndrome and is an important factor in selecting treatment type and evaluation of treatment response. The aim of this study was to evaluate retrospectively classical...

  • Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome. Nagoshi, H.; Horiike, S.; Kuroda, J.; Taniwaki, M. // Current Molecular Medicine;Nov2011, Vol. 11 Issue 8, p678 

    Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematological disorders characterized by ineffective hematopoiesis which causes peripheral cytopenias and a risk of progression to acute myeloid leukemia. Although various forms of chromosomal abnormalities have been detected in...

  • Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution. Bernasconi, Paolo; Klersy, Catherine; Boni, Marina; Cavigliano, Paola; Giardini, Ilaria; Rocca, Barbara; Zappatore, Rita; Dambruoso, Irene; Calvello, Celeste; Caresana, Marilena; Lazzarino, Mario // Annals of Hematology;Jun2010, Vol. 89 Issue 6, p545 

    The present study was designed to establish the incidence of cytogenetic evolution (CE), defined as the acquisition of chromosomal defects during the course of MDS, in order to correlate it with the WHO classification and IPSS score, and to assess its impact on overall survival (OS) and risk of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics